Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial thiol-containing molecules and enzymes are essential components of the microbial antioxidant defense system and redox homeostasis (Newton et al., 2008, MMBR). This group encompasses low-molecular-weight (LMW) thiols—such as glutathione (GSH), mycothiol (MSH), and bacillithiol (BSH)—and the enzymes that maintain them, including thioredoxin reductase (TrxR) and glutaredoxins (Fahey, 2013, Free Radic Biol Med). These systems protect bacteria from oxidative damage caused by reactive oxygen species (ROS) generated during metabolism or by the host immune response during infection (Antelmann & Helmann, 2011, Antioxid Redox Signal). Because many of these pathways are distinct from human redox systems—for instance, the specific use of mycothiol in Actinobacteria or the structural differences in bacterial TrxR—they represent promising targets for novel antimicrobial therapies (Harbut et al., 2015, PNAS). Drugs like auranofin target these systems by inhibiting thioredoxin reductase, leading to a lethal accumulation of ROS and the collapse of the bacterial redox network (Thangamani et al., 2016, Sci Rep). Targeting these thiol-dependent pathways is particularly relevant for treating multi-drug resistant infections where traditional antibiotic mechanisms have failed.
Inhibition of thioredoxin reductase, depletion of low-molecular-weight thiols, covalent modification of cysteine residues, induction of oxidative stress
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial thiol-containing molecules and enzymes (null).